Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ENGN

enGene Therapeutics Inc.

CIK 0001980845 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$1.78
↑ 0.01 (0.56%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options; Risks: Fundamentals, Technicals

Key stats

Market Cap
$119.24M
P/E Ratio
-0.94
EPS
2.29
Dividend Yield
Not covered
52W Position
4%
Beta
2.28

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.47
P/S
Not covered
EV/Revenue
Not covered
ROE
-49.7%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 4%
$1.40$12.25

Latest Financials

2025-10-31 FY
Revenue
–
Net Income
-$117.30M
Total Assets
$221.47M
Free Cash Flow
-$100.72M

Recent news